Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    0.00 (0.00%)
Bid:
2,320.00
Ask:
2,325.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

15 Jun 2023 07:00

RNS Number : 7618C
RIT Capital Partners PLC
15 June 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

15 June 2023

31 May 2023 Net Asset Value

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 31 May 2023 (with debt at fair value) was 2,348p per £1 ordinary share (30 April 2023: 2,367p).

 

May 2023 Highlights

Global equity markets were flat in May, although this concealed wide differences in performance across and within regional indices. For example, the FTSE All-share declined by -4.7%, China's CSI 300 was down -5.6%, and the S&P 500 equal-weighted index was down -3.8%. By contrast, the focus on Artificial Intelligence boosted a select group of mega-cap technology shares, pushing the NASDAQ 100 higher by nearly +7.7%. Economic news was also mixed with survey data indicating further weakness in the manufacturing sector, whilst services proved more robust. 

· The Quoted Equities book saw positive performance from Japan and Value holdings, offset by weakness in China and Quality Defensive holdings.

· In our Private Investments book, as of 31 May, ~76% of our private funds had reported valuations to 31 March, with ~24% held at 31 December valuations. Q1 marks received to date have led to a positive contribution to NAV, mainly driven by gains from holdings in the Digital Transition theme.

· Our Uncorrelated Strategies book was flat as positive contributions from European credit strategies were offset by market neutral strategies and a decline in the gold price.

· Currency movements contributed positively during the month, reflecting our active risk management approach to currency exposure in the portfolio.

· The Board continued to buy back shares during the month, directly benefitting shareholders via the accretive impact to NAV per share. In the month of May, the company repurchased approximately 1.0 million shares on behalf of shareholders.

· We continue to hold a substantial liquidity balance in the portfolio. As at 31 May, total cash and short-term gilts were approximately £369 million.

 

About RIT Capital Partners plc

RIT Capital Partners plc is an investment company listed on the London Stock Exchange. The Company's investment manager is J. Rothschild Capital Management Limited (JRCM), led by its Executive Committee: CEO Francesco Goedhuis, CIO Ron Tabbouche, CFOO Andrew Jones and CSO Aron Balas. JRCM is authorised and regulated by the FCA.

Website: www.ritcap.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDZLFFXQLFBBB
Date   Source Headline
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:00 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 202312:23 pmRNSTotal Voting Rights
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20237:00 amRNSTransaction in Own Shares
23rd Mar 20237:00 amRNSTransaction in Own Shares
22nd Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSTransaction in Own Shares
20th Mar 20237:00 amRNSTransaction in Own Shares
17th Mar 20237:00 amRNSTransaction in Own Shares
16th Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20237:00 amRNSTransaction in Own Shares
14th Mar 20237:00 amRNSNet Asset Value(s)
13th Mar 202312:51 pmRNSUpdate on Silicon Valley Bank
8th Mar 20231:21 pmRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSTransaction in Own Shares
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSTransaction in Own Shares
3rd Mar 20237:00 amRNSTransaction in Own Shares
2nd Mar 20237:00 amRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTransaction in Own Shares
28th Feb 20237:00 amRNSAnnual Financial Report
20th Feb 20237:00 amRNSNet Asset Value(s)
9th Feb 20235:00 pmRNSComposition of Board Committee
7th Feb 20237:00 amRNSNet Asset Value(s)
21st Dec 202212:52 pmRNSDirector/PDMR Shareholding
21st Dec 20227:00 amRNSTransaction in Own Shares
19th Dec 20225:20 pmRNSDirector/PDMR Shareholding
19th Dec 20227:00 amRNSTransaction in Own Shares
16th Dec 20227:00 amRNSTransaction in Own Shares
15th Dec 20227:00 amRNSNet Asset Value(s)
8th Dec 20227:00 amRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 20227:00 amRNSTransaction in Own Shares
15th Nov 20227:00 amRNSNet Asset Value(s)
14th Oct 20227:00 amRNSNet Asset Value(s)
3rd Oct 20227:00 amRNSTransaction in Own Shares
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
26th Sep 20227:00 amRNSTransaction in Own Shares
20th Sep 20227:00 amRNSTransaction in Own Shares
16th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20227:00 amRNSNet Asset Value(s)
7th Sep 20227:00 amRNSTransaction in Own Shares
6th Sep 20227:00 amRNSTransaction in Own Shares
17th Aug 20225:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.